EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review

Dhir Gala iD, Fady Botros iD, Amgad N Makaryus iD

Reviews in Cardiovascular Medicine · 18.12.2025 · 26 (12)

DOI: 10.31083/rcm45204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 18.12.2025. Verfasst von Dhir Gala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a prominent cardiovascular risk factor, especially among patients with diabetes and obesity. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of drugs originally developed to improve glycemic control in patients with diabetes; however, these agonists have subsequently demonstrated additional cardioprotective effects, including modest reductions in blood pressure (BP). This literature review examines the various mechanisms through which GLP-1 RAs reduce BP, including weight loss, improved endothelial function, and renal sodium management. While GLP-1 RAs are less potent in BP reduction compared to conventional antihypertensive agents, the broader metabolic benefits of these agonists make this class of drug a valuable adjunct in managing hypertension, particularly in patients with metabolic syndrome. Nonetheless, further studies are needed to explore the long-term effects of BP and optimize patient selection for maximal cardiovascular benefit.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasediabetesglucagon-like peptide-1 receptor agonistshypertensionmetabolic syndromeweight loss

Autor:innen und Institutionen

  • Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Department of Cardiology, Cardiovascular Institute, Northwell Health, New Hyde Park, NY 11040, USA.
  • Department of Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.

ORCID-Profile: Dhir Gala, Fady Botros, Amgad N Makaryus

Zitieren

APA

Gala, D., Botros, F., & Makaryus, A. N. (2025). The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review. Reviews in Cardiovascular Medicine, 26(12). https://doi.org/10.31083/rcm45204

Vancouver

Gala D, Botros F, Makaryus AN. The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review. Reviews in Cardiovascular Medicine. 2025;26(12). doi:10.31083/rcm45204

BibTeX
@article{Gala2025,
  author = {Gala, Dhir and Botros, Fady and Makaryus, Amgad N},
  title = {The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2025},
  volume = {26},
  number = {12},
  doi = {10.31083/rcm45204}
}
Kostenlos starten →